Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Acq. announced Auditor change Quarterly results Director departure CC transcript
|
Volcano Corp (VOLC)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/06/2014 |
8-K
| Quarterly results |
08/07/2014 |
8-K
| Quarterly results |
05/02/2014 |
8-K
| Quarterly results |
02/24/2014 |
8-K
| Quarterly results |
11/04/2013 |
8-K
| Quarterly results |
08/05/2013 |
8-K
| Quarterly results |
05/02/2013 |
8-K
| Quarterly results |
02/21/2013 |
8-K
| Quarterly results |
11/06/2012 |
8-K
| Quarterly results |
08/02/2012 |
8-K
| Form 8-K - Current report |
05/02/2012 |
8-K
| Quarterly results |
10/31/2011 |
8-K
| Form 8-K - Current report |
08/01/2011 |
8-K
| Quarterly results |
05/04/2011 |
8-K
| Form 8-K - Current report |
11/03/2010 |
8-K
| Quarterly results |
07/30/2010 |
8-K
| Form 8-K - Current report |
05/03/2010 |
8-K
| Quarterly results
Docs:
|
"VOLCANO REPORTS 36 PERCENT INCREASE IN FIRST QUARTER REVENUES IVUS DISPOSABLE AND FM DISPOSABLE REVENUES GROW 32 PERCENT AND 69 PERCENT, RESPECTIVELY May 3, 2010—Volcano Corporation , a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that revenues for the first quarter of 2010 increased 36 percent over the first quarter of 2009. For the quarter ended March 31, 2010, Volcano reported revenues of $66.6 million compared with revenues of $49.0 million a year ago. For the first quarter of 2010, the company reported a net loss on a GAAP basis of $4.0 million, or $0.08 per share, versus a net loss on a GAAP basis of $7.6 million, or $0.16 per share, in the s..." |
|
11/05/2009 |
8-K
| Form 8-K - Current report |
08/04/2009 |
8-K
| Quarterly results
Docs:
|
"VOLCANO REPORTS 30 PERCENT INCREASE IN SECOND QUARTER REVENUES CORE IVUS AND FM BUSINESSES GROW 21 PERCENT, DRIVEN BY DISPOSABLE SALES AND CONSOLE PLACEMENTS , August 4, 2009—Volcano Corporation , a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported revenues of $54.0 million for the second quarter of fiscal 2009. The results for the quarter ended June 30, 2009, represent an increase of 30 percent over revenues of $41.5 million in the second quarter of 2008. The revenues for the second quarter of 2009 include $3.9 million from Axsun Technologies, Inc., which Volcano acquired at the end of 2008 and for which the company recorded no revenues in the second quarter a year ago. For the second qu..." |
|
05/05/2009 |
8-K
| Form 8-K -- Current report |
11/05/2008 |
8-K
| Quarterly results |
08/05/2008 |
8-K
| Quarterly results
Docs:
|
"VOLCANO CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS June 30, December 31, 2008 2007 Assets Current assets: Cash and cash equivalents $ 122,851 $ 122,913 Short-term available-for-sale investments 55,413 66,205 Accounts receivable, net 22,662 27,976 Inventories, net 23,459 21,243 Prepaid expenses and other current assets 4,014 3,997 Total current assets 228,399 242,334 Restricted cash 375 365 Property and equipment, net 16,493 13,692 Intangible assets, net 8,161 9,385 Other non-current assets 912 798 $ 254,340 $ 266,574 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 10,567 $ 11,077 Accrued compensation 8,938 9,083 Accrued expenses and other current liabilities 6,687 6,600 Deferred revenues 5,099 5,360 Current maturities of long-term debt 58 120 Total curr..." |
|
05/07/2008 |
8-K
| Quarterly results |
02/12/2008 |
8-K
| Quarterly results |
11/08/2007 |
8-K
| Quarterly results |
05/07/2007 |
8-K
| Quarterly results |
02/13/2007 |
8-K
| Quarterly results |
11/01/2006 |
8-K
| Quarterly results |
08/08/2006 |
8-K
| Quarterly results |
|
|